Low Testosterone at First PSA Failure and Assessment of the Risk of Death in Men with Unfavorable-Risk Prostate Cancer Treated on Prospective Clinical Trials

類似資料

• Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial
  著者:: Giacalone, Nicholas J., 等
  出版事項: (2016)
• Impact of Time to Testosterone Rebound and Comorbidity on the Risk of Cause-Specific Mortality in Men with Unfavorable-Risk Prostate Cancer
  著者:: McDuff, Susan G. R., 等
  出版事項: (2018)
• Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
  著者:: Sanford, Nina N., 等
  出版事項: (2016)
• Time to PSA Nadir and the Risk of Death from Prostate Cancer following Radiation and Androgen Deprivation Therapy
  著者:: Pike, Luke R.G., 等
  出版事項: (2019)
• Evaluating the Combined Effect of Comorbidity and Prostate-Specific Antigen Kinetics on the Risk of Death in Men After Prostate-Specific Antigen Recurrence
  著者:: Wo, Jennifer Y., 等
  出版事項: (2009)